We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.48%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.8B
AUM Growth
+$629M
Cap. Flow
-$312M
Cap. Flow %
-2.1%
Top 10 Hldgs %
24.14%
Holding
917
New
50
Increased
256
Reduced
457
Closed
57

Top Buys

Rank Stock Value
1
VERU icon
Veru
VERU
+$53M
2
MELI icon
Mercado Libre
MELI
+$43.2M
3
DAR icon
Darling Ingredients
DAR
+$41.7M
4
JNJ icon
Johnson & Johnson
JNJ
+$33.7M
5
MET icon
MetLife
MET
+$31.1M

Top Sells

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$46.1M
2
NKE icon
Nike
NKE
+$36.6M
3
ITW icon
Illinois Tool Works
ITW
+$35.8M
4
AAPL icon
Apple
AAPL
+$31.9M
5
GILD icon
Gilead Sciences
GILD
+$29.8M

Sector Composition

Rank Sector Weight
1 Healthcare 33.32%
2 Technology 22.84%
3 Financials 10.04%
4 Consumer Discretionary 7.69%
5 Industrials 7.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DOCU
626
DocuSign
DOCU
$10.7B
$1.34M 0.01%
24,117
-5,221
-18% -$254K
ONC
627
BeOne Medicines Ltd
ONC
$34.3B
$1.33M 0.01%
6,033
+1,152
+24% +$211K
FOXA icon
628
Fox Class A
FOXA
$24.2B
$1.32M 0.01%
43,484
-12,522
-22% -$382K
HRI icon
629
Herc Holdings
HRI
$4.95B
$1.32M 0.01%
+10,000
New +$1.23M
MTB icon
630
M&T Bank
MTB
$36.6B
$1.31M 0.01%
9,022
-1,305
-13% -$215K
DVA icon
631
DaVita
DVA
$15.4B
$1.31M 0.01%
17,517
-1,026
-6% -$79.7K
NET icon
632
Cloudflare
NET
$93.7B
$1.29M 0.01%
28,636
-4,064
-12% -$201K
TDOC icon
633
Teladoc Health
TDOC
$1.69B
$1.29M 0.01%
54,579
-26,836
-33% -$724K
CPAY icon
634
Corpay
CPAY
$25.1B
$1.29M 0.01%
6,998
-2,368
-25% -$434K
FDS icon
635
Factset
FDS
$10.1B
$1.28M 0.01%
3,191
-152
-5% -$64.7K
TER icon
636
Teradyne
TER
$50.2B
$1.28M 0.01%
14,620
-3,784
-21% -$324K
PWR icon
637
Quanta Services
PWR
$88.3B
$1.24M 0.01%
+8,711
New +$1.24M
BKI
638
DELISTED
Black Knight, Inc. Common Stock
BKI
$1.23M 0.01%
19,981
+7,147
+56% +$434K
CPRT icon
639
Copart
CPRT
$28.4B
$1.23M 0.01%
40,246
-261,258
-87% -$7.82M
MTCH icon
640
Match Group
MTCH
$9.16B
$1.21M 0.01%
29,106
-19,300
-40% -$873K
BF.B icon
641
Brown-Forman Class B
BF.B
$13.3B
$1.2M 0.01%
18,295
-47,837
-72% -$3.25M
BILL icon
642
BILL Holdings
BILL
$4.62B
$1.19M 0.01%
10,914
-1,937
-15% -$233K
GLW icon
643
Corning
GLW
$108B
$1.19M 0.01%
37,136
-5,266
-12% -$171K
KMX icon
644
CarMax
KMX
$8.36B
$1.18M 0.01%
19,355
-2,445
-11% -$157K
TECH icon
645
Bio-Techne
TECH
$11.2B
$1.16M 0.01%
14,022
-2,782
-17% -$221K
HON icon
646
Honeywell
HON
$78.3B
$1.15M 0.01%
5,694
-5,811
-51% -$1.11M
ARKF icon
647
ARK Blockchain & Fintech Innovation ETF
ARKF
$744M
$1.15M 0.01%
80,552
SE icon
648
Sea Limited
SE
$65.8B
$1.13M 0.01%
21,787
+2,349
+12% +$127K
TECK icon
649
Teck Resources
TECK
$28.8B
$1.12M 0.01%
29,774
+4,834
+19% +$167K
CRL icon
650
Charles River Laboratories
CRL
$11.6B
$1.12M 0.01%
5,153
-46,301
-90% -$10.1M

Similar funds

Candriam SCA's Q4 2022 Portfolio in Review

As of Q4 2022, Candriam SCA held 917 positions worth $14.8B, up 4.4% from $14.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Candriam SCA's Q4 2022 filing shows 50 new, 256 increased, 457 reduced and 57 closed positions. Its largest new stake was Sarepta Therapeutics: 95,144 shares worth $12.3M. The largest sale was PepsiCo, an estimated $46.1M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 32% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2022 buy was Sarepta Therapeutics: 95,144 shares worth $12.3M.
  • Candriam SCA added most to Veru in Q4 2022, an estimated $53M increase.
  • Candriam SCA's biggest Q4 2022 reduction was PepsiCo, cutting an estimated $46.1M.
  • Candriam SCA fully exited Global Blood Therapeutics, Inc. in Q4 2022, selling an estimated $24.6M.
  • Candriam SCA's ten largest holdings make up 24% of its $14.8B portfolio in Q4 2022.
  • Candriam SCA opened 50 new positions and closed 57 in Q4 2022.
  • Candriam SCA's portfolio value rose 4.4% quarter-over-quarter to $14.8B.

Based on Candriam SCA's 13F filing for Q4 2022, filed 13 Feb 2023.